Author

A. Gessner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Assay:metagenomics· 1 Organism:mouse· 1

Frequent Co-Authors

D. Peterhoff· 2 shared S. Blaas· 2 shared A. Haghikia· 1 shared A. J. Walter· 1 shared A. Mohr· 1 shared B. Salzberger· 1 shared B. Schmidt· 1 shared C. A. Akdis· 1 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

D. Peterhoff

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Gut-specific H3R signaling orchestrates microglia-dependent resolution of peripheral inflammation

K. Duerholz, M. Linnerbauer, E. Schmid, H. Danzer, L. Loesslein, L. Amend, L. Ehnes, M. Frech, V. Azizov, F. Schaelter, A. Gessner, S. Lucas, T.-R. Lesker, R. V. Taudte, J. Hofmann, , M. M. Zaiss

The paper identifies gut microbiota-derived histamine as a factor enabling the CNS to suppress peripheral inflammation in RA by activating H3R in the intestine and modulating microglia.

bioRxiv · Jul 11, 2024 · PreprintImmunology

IgG4 serum levels are not elevated in cases of Post-COVID syndrome

J. Abel, A. J. Walter, V. Glueck, C. L. Magnus, T. Glueck, P. Schuster, S. Blaas, I. Montanari, M. Koller, A. Mohr, T. Hinterberger, B. Salzberger, K. Renner, M. Mack, R. Bals, , D. Peterhoff

The paper compares IgG subtypes in Post-COVID patients and controls, finding no elevation in IgG4 but reduced IgG2, suggesting potential role of IgG2 in Post-COVID syndrome.

bioRxiv · Mar 1, 2023 · PreprintImmunology

Scorpionfish BPI is highly active against multiple drug-resistant Pseudomonas aeruginosa isolates from cystic fibrosis patients

J. M. Holzinger, M. Toelge, M. Werner, K. U. Ederer, H. I. Siegmund, D. Peterhoff, S. Blaas, N. Gisch, C. Brochhausen-Delius, A. Gessner, S. Bülow

The paper shows that scorpionfish-derived BPI (scoBPI) is effective against drug-resistant Pseudomonas aeruginosa in CF patients, even when human BPI is neutralized by autoantibodies.

bioRxiv · Feb 19, 2023Microbiology